VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

RWE Economic Modeling Intern

Johnson & Johnson is a leader in healthcare innovation, focused on developing advanced treatments and solutions. The Economic Modeling and Real-World Evidence Intern will support the generation of high-quality evidence through economic modeling and literature review, helping to deliver scientific insights for decision-making across the product lifecycle.

Former Chairman and CEO, Johnson & Johnson

Chairman of the Board and Chief Executive Officer

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Johnson &amp; Johnson price target raised by $21 at Bernstein, here's why

Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Johnson & Johnson is a leader in healthcare innovation, seeking an Evidence & Modeling Analytics Intern to support their Innovative Scientific Analytics team. The intern will assist in developing economic models and conducting literature reviews to generate high-quality evidence for decision-making in healthcare.

Rwe Economic Modeling Intern

Rwe Economic Modeling Intern in united states (1000+)

RWE Economic Modeling Intern

RWE Economic Modeling Intern